
    
      A multicenter, randomized, open-label Phase IV study exploring symptom control rate in
      co-diagnosed NERD and chronic gastritis patients treated with 8 weeks esomeprazole treatment
      regimen and 2 weeks esomeprazole treatment regimen.
    
  